Definium Therapeutics, Inc. (DFTX) is listed on NASDAQ in Pharmaceutical Stocks. It is $40.94, -6.57%, with a $5.5B market cap. RSI is 41.9, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 41.9 Neutral
Market Cap $5.5B
Volume 1.7M
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-236.1M
EPS $-2.15
Debt / Equity 0.0x
P/E Ratio -19.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Sullivan Mark | Chief Legal Officer | Sell | 13,008 | $45.03 | $585,750 | 2026 Jun 25 |
| Roberts Brandi | Chief Financial Officer | Sell | 3,013 | $45.03 | $135,675 | 2026 Jun 25 |
| Barrow Robert | Chief Executive Officer | Sell | 29,208 | $45.03 | $1.3M | 2026 Jun 25 |
| Karlin Daniel | Chief Medical Officer | Sell | 10,035 | $45.03 | $451,876 | 2026 Jun 25 |
| Wiley Matthew T. | Chief Commercial Officer | Sell | 2,867 | $45.03 | $129,101 | 2026 Jun 25 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $280.77 | 42.4 | $5.6B |
| | $65.68 | 62.9 | $6.2B |
| | $34.67 | 38.7 | $6.0B |
| | $33.21 | 63.0 | -- |
| | $91.15 | 37.5 | $6.0B |
Take DFTX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DFTX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Definium Therapeutics, Inc. next reports.
Set alerts on DFTX
Get notified when Definium Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free